Taiwan FDA registration 9ca4e21df8ccd6a313e7e6a1c88b2a94
"Hannitec" de-leukocyte blood processing filtration system
TW: “漢尼帝克” 去白血球血液處理過濾系統
Taiwan·Risk Class 2·Haemonetics Manufacturing, Inc.·Registered Jul 16, 2012 – Jul 16, 2022CancelledRegistration details
- Analysis ID
- 9ca4e21df8ccd6a313e7e6a1c88b2a94
- Customs Code
- DHA00602377102
Company information
- Manufacturer
- Haemonetics Manufacturing, Inc.
- Manufacturer Country
- United States
- Authorized Representative
- HAEMONETICS ASIA INCORPORATED TAIWAN BRANCH (U.S.A.)
Product details
- Intended Use
- For details, it is Chinese approved copy of the imitation order
- Product Type (Level 1)
- B Hematology, pathology, and genetics
- Product Type (Level 2)
- B.9100 Containers for the collection and disposal of blood and blood components
- Import Information
- import
Dates and status
- Registration Date
- Jul 16, 2012
- Expiry Date
- Jul 16, 2022
- Cancellation Date
- Apr 12, 2024
Cancellation information
- Status
- Logged out
- Reason
- 許可證已逾有效期
About this record
Access comprehensive regulatory information for "Hannitec" de-leukocyte blood processing filtration system in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 9ca4e21df8ccd6a313e7e6a1c88b2a94 and manufactured by Haemonetics Manufacturing, Inc.. The authorized representative in Taiwan is HAEMONETICS ASIA INCORPORATED TAIWAN BRANCH (U.S.A.).
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices